Hygea Medical Raises $77 Million for Minimally Invasive Surgery Devices

Beijing Hygea Medical Technology completed a $77 million Series C financing to support its medical devices, including a low temperature minimally invasive ablation device for cancer and atrial fibrillation. Hygea said it would use the proceeds to accelerate its marketing and build a sales channel for its core product, the Kangbo Knife. The company has started an AI program to develop new minimally invasive surgery products. It is also applying its ablation technology to treat atrial fibrillation. The financing was led by China Growth Capital. More details.... Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.